Prognostic tools for cancer survival: A secondary role for quality-of-life measurement

Journal of Clinical Oncology

Volumn 27, Issue 18, 2009, Pages 2902-2904

  Browman, George P ^a,b   Berrang, Tanya ^b   Smith, Sally ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; PROSTATE SPECIFIC ANTIGEN;

CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; EDITORIAL; EMOTIONAL STRESS; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEAD AND NECK CANCER; HUMAN; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; QUALITY OF LIFE; QUALITY OF LIFE INDEX; RATING SCALE; RISK ASSESSMENT; SOCIAL PSYCHOLOGY; SQUAMOUS CELL CARCINOMA; VALIDITY; HEAD AND NECK TUMOR; NOTE;

HEAD AND NECK NEOPLASMS; HUMANS; PROGNOSIS; QUALITY OF LIFE;

EID: 67649983326     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.21.8438     Document Type: Editorial

References (18)

1. Ravdin PM, Siminoff IA, Harvey JA: Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol 16:515-521, 1998
2. List MA, Stracks J, Colangelo L, et al: How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol 18:877-884, 2000
3. Browman GP, Cronin L: Standard chemotherapy in squamous cell head and neck cancer: What have we learned from randomized trials? Semin Oncol 21:311-319, 1994
4. Walid SW, Donahue SN, Darmohray DM, et al: The fifth vital sign: What does it mean? Pain Pract 8:417-422, 2008
5. Bultz BD, Carlson LE: Emotional distress: The sixth vital sign in cancer care. J Clin Oncol 23:6440-6441, 2005
6. Canadian Partnership Against Cancer: Cancer journey. http://www. partnershipagainstcancer.ca/journey
7. Osoba D: The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: Organization and functions. Qual Life Res 1:211-218, 1992
8. Gotay CC, Moore TD: Assessing quality of life in head and neck cancer. Qual Life Res 1:5-17, 1992
9. Rogers SN, Ahad SA, Murphy AP: A structured review and theme analysis of papers published on "quality of life" in head and neck cancer: 2000-2005. Oral Oncol 43:843-868, 2007
10. Spiegel D, Kraemer HC, Bloom JR, et al: Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888-891, 1989
11. Meyer F, Fortin A, Gélinas M, et al: Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy. J Clin Oncol 27:2970-2976, 2009
12. Bairati I, Meyer F, Gélinas M, et al: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 97:481-488, 2005
13. Bairati I, Meyer F, Jobin E, et al: Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients. Int J Cancer 119:2221-2234, 2006
14. Bairati I, Meyer F, Gélinas M, et al: Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol 23:5805-5813, 2005
15. Smart A: A multi-dimensional model of clinical utility. Int J Qual Health Care 18:377-382, 2006
16. Twombly R: Preventive Services Task Force recommends against PSA screening after age 75. J Natl Cancer Inst 100:1571-1573, 2008
17. Bruera E, Hui D: Practical model for prognostication in advanced cancer patients: Is less more? J Clin Oncol 26:5843-5844, 2008
18. Sloan JA, Loprinzi CL, Laurine JA, et al: A simple stratification factor prognostic for survival in advanced cancer: The good/bad/uncertain index. J Clin Oncol 19:3539-3546, 2001